FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981738178> ?p ?o ?g. }

• W2981738178 endingPage "1644" @default.
• W2981738178 startingPage "1644" @default.
• W2981738178 abstract "Aberrant SRC expression and activation is frequently detected in multiple cancers, and hence, targeting SRC has emerged as a promising therapeutic strategy. Different SRC inhibitors have demonstrated potent anti-tumor activity in preclinical models, although they largely lack clinical efficacy as monotherapy in late-stage solid tumors, including head and neck squamous cell carcinomas (HNSCC). Adequate selection and stratification of patients who may respond to and benefit from anti-SRC therapies is therefore needed to guide clinical trials and treatment efficacy. This study investigates the prognostic significance of active SRC expression in a homogeneous cohort of 122 human papillomavirus (HPV)-negative, surgically treated HNSCC patients. Immunohistochemical evaluation of the active form of SRC by means of anti-SRC Clone 28 monoclonal antibody was specifically performed and subsequently correlated with clinical data. The expression of p-SRC (Tyr419), total SRC, and downstream SRC effectors was also analyzed. Our results uncovered striking differences in the prognostic relevance of SRC expression in HNSCC patients depending on the tumor site. Active SRC expression was found to significantly associate with advanced disease stages, presence of lymph node metastasis, and tumor recurrences in patients with laryngeal tumors, but not in the pharyngeal subgroup. Multivariate Cox analysis further revealed active SRC expression as an independent predictor of cancer-specific mortality in patients with laryngeal carcinomas. Concordantly, expression of p-SRC (Tyr419) and the SRC substrates focal adhesion kinase (FAK) and the Arf GTPase-activating protein ASAP1 also showed specific associations with poor prognosis in the larynx. These findings could have important implications in ongoing Src family kinase (SFK)-based clinical trials, as these new criteria could help to improve patient selection and develop biomarker-stratified trials." @default.
• W2981738178 created "2019-11-01" @default.
• W2981738178 creator A5004034328 @default.
• W2981738178 creator A5008617030 @default.
• W2981738178 creator A5031995017 @default.
• W2981738178 creator A5033876044 @default.
• W2981738178 creator A5043143519 @default.
• W2981738178 creator A5045167647 @default.
• W2981738178 creator A5067795786 @default.
• W2981738178 creator A5073897488 @default.
• W2981738178 creator A5074166753 @default.
• W2981738178 creator A5078191199 @default.
• W2981738178 creator A5089233479 @default.
• W2981738178 date "2019-10-25" @default.
• W2981738178 modified "2023-10-18" @default.
• W2981738178 title "The Differential Impact of SRC Expression on the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma" @default.
• W2981738178 cites W1559021784 @default.
• W2981738178 cites W1589166971 @default.
• W2981738178 cites W1818470125 @default.
• W2981738178 cites W1969224935 @default.
• W2981738178 cites W1970213932 @default.
• W2981738178 cites W1977455794 @default.
• W2981738178 cites W1979924183 @default.
• W2981738178 cites W1990915902 @default.
• W2981738178 cites W1992331087 @default.
• W2981738178 cites W1992831404 @default.
• W2981738178 cites W1997148726 @default.
• W2981738178 cites W1998872597 @default.
• W2981738178 cites W2003405179 @default.
• W2981738178 cites W2009651510 @default.
• W2981738178 cites W2011707243 @default.
• W2981738178 cites W2013491729 @default.
• W2981738178 cites W2019565481 @default.
• W2981738178 cites W2024161072 @default.
• W2981738178 cites W2026279585 @default.
• W2981738178 cites W2030565228 @default.
• W2981738178 cites W2036988959 @default.
• W2981738178 cites W2046679772 @default.
• W2981738178 cites W2049129806 @default.
• W2981738178 cites W2052081346 @default.
• W2981738178 cites W2059854067 @default.
• W2981738178 cites W2061099439 @default.
• W2981738178 cites W2066715177 @default.
• W2981738178 cites W2068326740 @default.
• W2981738178 cites W2076797886 @default.
• W2981738178 cites W2078155300 @default.
• W2981738178 cites W2109218103 @default.
• W2981738178 cites W2112833912 @default.
• W2981738178 cites W2113615565 @default.
• W2981738178 cites W2114963275 @default.
• W2981738178 cites W2115674731 @default.
• W2981738178 cites W2119820217 @default.
• W2981738178 cites W2124254102 @default.
• W2981738178 cites W2134167319 @default.
• W2981738178 cites W2138501030 @default.
• W2981738178 cites W2150125913 @default.
• W2981738178 cites W2150310014 @default.
• W2981738178 cites W2158561889 @default.
• W2981738178 cites W2160318185 @default.
• W2981738178 cites W2161873278 @default.
• W2981738178 cites W2333237625 @default.
• W2981738178 cites W2529083835 @default.
• W2981738178 cites W2593973360 @default.
• W2981738178 cites W2599316103 @default.
• W2981738178 cites W2602330969 @default.
• W2981738178 cites W2605142816 @default.
• W2981738178 cites W2605888590 @default.
• W2981738178 cites W2733322317 @default.
• W2981738178 cites W2766382617 @default.
• W2981738178 cites W2784258094 @default.
• W2981738178 cites W2791994878 @default.
• W2981738178 cites W2793226176 @default.
• W2981738178 cites W2964915016 @default.
• W2981738178 cites W2967470918 @default.
• W2981738178 doi "https://doi.org/10.3390/cancers11111644" @default.
• W2981738178 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6896085" @default.
• W2981738178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31731442" @default.
• W2981738178 hasPublicationYear "2019" @default.
• W2981738178 type Work @default.
• W2981738178 sameAs 2981738178 @default.
• W2981738178 citedByCount "9" @default.
• W2981738178 countsByYear W29817381782020 @default.
• W2981738178 countsByYear W29817381782021 @default.
• W2981738178 countsByYear W29817381782022 @default.
• W2981738178 countsByYear W29817381782023 @default.
• W2981738178 crossrefType "journal-article" @default.
• W2981738178 hasAuthorship W2981738178A5004034328 @default.
• W2981738178 hasAuthorship W2981738178A5008617030 @default.
• W2981738178 hasAuthorship W2981738178A5031995017 @default.
• W2981738178 hasAuthorship W2981738178A5033876044 @default.
• W2981738178 hasAuthorship W2981738178A5043143519 @default.
• W2981738178 hasAuthorship W2981738178A5045167647 @default.
• W2981738178 hasAuthorship W2981738178A5067795786 @default.
• W2981738178 hasAuthorship W2981738178A5073897488 @default.
• W2981738178 hasAuthorship W2981738178A5074166753 @default.
• W2981738178 hasAuthorship W2981738178A5078191199 @default.
• W2981738178 hasAuthorship W2981738178A5089233479 @default.
• W2981738178 hasBestOaLocation W29817381781 @default.

• next